e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Special treatment options in tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Primary multidrug-resistant tuberculosis: Serious and expensive disease
H. Daghfous, H. Zaibi, O. Kahloul, S. Merai, L. Slim, F. Tritar (Ariana, Tunisia)
Source:
Annual Congress 2010 - Special treatment options in tuberculosis
Session:
Special treatment options in tuberculosis
Session type:
Thematic Poster Session
Number:
3131
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Daghfous, H. Zaibi, O. Kahloul, S. Merai, L. Slim, F. Tritar (Ariana, Tunisia). Primary multidrug-resistant tuberculosis: Serious and expensive disease. Eur Respir J 2010; 36: Suppl. 54, 3131
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Primary multi-drug resistant tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004
Pulmonary tuberculosis with primary drug resistant mycobacterium tuberculosis -treatment outcomes
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004
Management and treatment of multidrug-resistant tuberculosis
Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management
Year: 2019
Nonspecific microflora in patients associated with pulmonary multidrug-resistant tuberculosis
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Management of MDR tuberculosis
Source: Short video discussion 2021
Year: 2021
Surgical treatment of multidrug-resistant tuberculosis (MDR TB)
Source: Eur Respir J 2003; 22: Suppl. 45, 523s
Year: 2003
Analysis of multidrug-resistant tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction
Source: Eur Respir Rev 2009; 18: 295-299
Year: 2009
Management of multidrug-resistant tuberculosis and patients in retreatment
Source: Eur Respir J 2005; 25: 928-936
Year: 2005
Primary drug resistance against mycobacterium tuberculosis in a high burden country
Source: Eur Respir J 2006; 28: Suppl. 50, 587s
Year: 2006
Evaluation of treatment outcomes for multidrug-resistant tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 312s
Year: 2001
Epidemiology of TB
Source: Eur Respir Mon 2012; 58: 14-25
Year: 2012
The efficiency of surgical treatment for multidrug-resistant pulmonary and pleural tuberculosis
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
Treatment of TB
Source: Eur Respir Mon 2012; 58: 154-166
Year: 2012
Outcome of pulmonary multidrug-resistant tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 419s
Year: 2007
Surgical approach to multidrug-resistant pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 323s
Year: 2003
Early diagnosis of sub-clinical multidrug-resistant tuberculosis
Source: Annual Congress 2003 - The various appearance of resistance
Year: 2003
Efficacy and safety of linezolid for the treatment of multidrug resistant tuberculosis (MDR-TB) and disease by non tuberculous mycobacteria (NTM)
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011
Diagnosis of COPD in patients with multidrug-resistant tuberculosis
Source: International Congress 2018 – COPD around the world
Year: 2018
Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India
Source: Eur Respir J 2012; 39: 956-962
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept